Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Xuzhou Medical University》 2019-06
Add to Favorite Get Latest Update

Overview of triple negative breast cancer

CHEN Lina;Department of Comprehensive Surgery,Coastal Hospital,General Hospital of Tianjin Medical University;  
Tri-negative breast cancer is a heterogeneous tumor.It is highly invasive,with a high early metastasis rate and low overall survival rate.Patients usually present metastasis and recurrence within 5 years after operation,where the recurrence peaks within 3 years,in addition to a short survival period after metastasis.At present,the treatment of triple negative breast cancer is limited.Chemotherapy is the only systemic treatment approach.Better understanding of the occurrence,prognosis and phenotypic heterogeneity of triple negative breast cancer can help improve the treatment.Pathological complete remission(pCR)is expected to be a suitable alternative for clinical assessment of prognosis of triple negative breast cancer in a long term.
【CateGory Index】: R737.9
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved